Company

AuXin Surgery was incorporated in Belgium in January 2014 as a limited liability company. The Company is the pioneer of devices for chemically assisted dissection (CADISS® Method) in surgery. The objective is to make available to surgeons this novel method for use in many surgical procedures. The Company develops and sells complete CADISS® systems for targeted applications..

AuXin Surgery is ISO 13485 (2016) certified.

Management Team

CAPART Gilles

MANAGING DIRECTOR

VERJANS Benoît

SUPPLY CHAIN DIRECTOR

FERRIERE Laurent

QUALITY DIRECTOR

GORDENNE Valérie

CHIEF SCIENTIFIC OFFICER

DELCORPS Xavier

MARKETING DIRECTOR

Shareholders

Giles Capart & family

Spinventure (ULg + Meusinvest)

Business angels (angels.be)

Collaborations

Scientific

Industrial

Financial

News & Events

Congresses / Expert presentation – CADISS®

All
Congresses
Seminars
Next AuXin congresses
Distributor congresses
Press
Jan
27
2020

Arabhealth | Dubai

CongressesNext Congresses
Nov
29
2019

German distributor Vostra | DWG Kongress | Munich

CongressesNext Congresses
Oct
16
2019

Eurospine | Helsinki

CongressesNext Congresses
Oct
11
2019

60th annual conference of the Irish ENT society | Dublin

CongressesNext Congresses
Oct
10
2019

Nordics distributor Mediplast | Årsmøde Dansk Otokirurgisk Selskab | Nyborg

CongressesNext Congresses
Sep
28
2019

125ème congrès SFORL | Paris

CongressesNext Congresses
Sep
13
2019

German distributor Vostra | 69. Österreichischen HNO-Kongress 2019 | Salzburg

CongressesNext Congresses
Sep
12
2019

UK distributor Delta Surgical | ENT UK September Annual Meeting 2019 | London

CongressesNext Congresses
Juil
12
2019

DEUX MILLIARDS D’EUROS LEVÉS PAR LES BIOTECHS WALLONNES DEPUIS 2005 | L’Echo

Press
Juin
29
2019

5th congress of European ORL-HNS | Brussels

Congresses

Careers

We are currently not looking for profiles